Document Preview Unavailable
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
Soldi, Raffaella; Tithi Ghosh Halder; Weston, Alexis; Thode, Trason; Drenner, Kevin; et al. bioRxiv, Jan 30, 2020.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library